期刊的影响因子--文章列表

期刊文章列表
Kenan Zhang，Xing Liu，Guanzhang Li，Xin Chang，Shouwei Li，Jing Chen，Zheng Zhao，Jiguang Wang，Tao Jiang，Ruichao Chai（Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University；Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University；Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University；Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University；Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay；Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park；HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute）.Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA[J].Cancer Biology & Medicine,2023,第7期 Zhuang Kang¹，Shan Li²，Xun Kang¹，Jing Deng³，Huarong Yang³，Feng Chen¹，Jiandong Jiang⁴，Jie Zhang³，Wenbin Li¹（Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University；Department of Oncology, Beijing Shijitan Hospital, Capital Medical University；Sichuan Jiuzhang Biological Science and Technology Co.Ltd；Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College）.Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up[J].Cancer Biology & Medicine,2023,第6期 Mei Feng^1,2，Fangyanni Wang³，Xinyu Liu¹，Tingting Hao¹，Ning Zhang^1,3,4，Mi Deng³，Yisheng Pan²，Ruirui Kong¹（Translational Cancer Research Center, Peking University First Hospital；Division of General Surgery,Peking University First Hospital；International Cancer Institute, Peking University Health Science Center；Yunnan Baiyao Group）.Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer[J].Cancer Biology & Medicine,2023,第6期 Jing Luo，Jiawei Song，Li Xiao³，Jiajia Zhang⁴，Yipeng Cao，Jun Wang，Ping Wang，Lujun Zhao，Ningbo Liu（Department of Immunology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy；Department of Oncology, Ganyu District People’s Hospital of Lianyungang City；Department of Oncology, Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine；Department of Radiation Oncology, Yantai Yuhuangding Hospital；Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital,National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer）.Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer[J].Cancer Biology & Medicine,2023,第6期 Meizhi Du¹，Yu Wang¹，Jillian Vallis²，Matin Shariati²，Patrick S.Parfrey³，John R.Mclaughlin⁴，Peizhong Peter Wang^2,4,5,6，Yun Zhu¹（Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University；Division of Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland；Clinical Epidemiology Unit, Faculty of Medicine, Memorial University of Newfoundland；Dalla Lana School of Public Health, University of Toronto；Beatrice Hunter Cancer Institute；Centre for New Immigrant Wellbeing）.Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival[J].Cancer Biology & Medicine,2023,第6期 Pinaki Banerjee¹，Prachi Kapse²，Shehnaz Siddique³，Moumita Kundu³，Jasoda Choudhari⁴，Varshasnata Mohanty³，Diksha Malhotra³，Suresh W.Gosavi²，Rajesh N.Gacche⁴，Gopal C.Kundu^3,5（National Centre for Cell Science, Savitribai Phule Pune University Campus；School of Basic Medical Science, Savitribai Phule Pune University；School of Biotechnology, KIIT Deemed to be University；Department of Biotechnology, Savitribai Phule Pune University；Kalinga Institute of Medical Sciences (KIMS), KIIT Deemed to be University）.Therapeutic implications of cancer stem cells in prostate cancer[J].Cancer Biology & Medicine,2023,第6期（Department of Neuro-oncology，Cancer Center，Beijing Tiantan Hospital，Capital Medical University；Department of Oncology，Beijing Shijitan Hospital，Capital Medical University，Beijing 100038，China；Sichuan Jiuzhang Biological Science and Technology Co.Ltd；Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Phase Ⅰ study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up[J].癌症生物学与医学（英文版）,2023,第6期 Lingxiang Wu^1,2，Ruichao Chai^3,4,5，Zihan Lin^1,2，Rongrong Wu^1,2，Diru Yao^1,2，Tao Jiang^3,4,5，Qianghu Wang^1,2（Department of Bioinformatics, Nanjing Medical University；Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University；Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University；Chinese Glioma Genome Atlas Network (CGGA)；Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University）.Evolution-driven crosstalk between glioblastoma and the tumor microenvironment[J].Cancer Biology & Medicine,2023,第5期 Chun Wang^1,2,3，Qiushi Li^1,2,3，Jian Xiao^1,2,3，Yang Liu^1,2,3（State Key Laboratory of Medicinal Chemical Biology, Nankai University；Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Nankai University；Frontiers Science Center for New Organic Matter, Nankai University）.Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas[J].Cancer Biology & Medicine,2023,第5期 Xiaoteng Cui，Yunfei Wang，Junhu Zhou，Qixue Wang，Chunsheng Kang（Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital）.Expert opinion on translational research for advanced glioblastoma treatment[J].Cancer Biology & Medicine,2023,第5期 Can Xu¹，Xiaoye Yuan²，Pengyu Hou²，Ziru Li²，Changsheng Wang¹，Chuan Fang^1,3，Yanli Tan^2,3,4（School of Clinical Medicine, Hebei University, Department of Neurosurgery, Affiliated Hospital of Hebei University；School of Basic Medical Sciences, Hebei University；Hebei Key Laboratory of Precise Diagnosis and Treatment of Glioma；Department of Pathology, Affiliated Hospital of Hebei University）.Development of glioblastoma organoids and their applications in personalized therapy[J].Cancer Biology & Medicine,2023,第5期 Yingyan Yu¹，Wenjie Peng²（Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine；Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University）.Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy[J].Cancer Biology & Medicine,2023,第5期 Junhu Zhou^1,2，Fei Tong^1,2，Jixing Zhao^1,2，Xiaoteng Cui^1,2，Yunfei Wang^1,2，Guangxiu Wang^1,2，Chunsheng Kang^1,2，Xiaomin Liu³，Qixue Wang^1,2（Tianjin Medical University General Hospital；Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government；Department of Oncology, Gamma Knife Center, Department of Neurological Surgery, Tianjin Huanhu Hospital, Nankai University）.Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance[J].Cancer Biology & Medicine,2023,第5期 Hongxia Chen¹，Luxi Yin¹，Jie Yang¹，Ningxin Ren¹，Jinna Chen¹，Qixuan Lu¹，Ying Huang¹，Yanru Feng²，Weihu Wang²，Shulian Wang²，Yueping Liu²，Yongwen Song²，Yexiong Li²，Jing Jin²，Wen Tan¹，Dongxin Lin^1,3（State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College；Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China）.Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy[J].Cancer Biology & Medicine,2023,第4期 Xue Wang¹，Jian Yue¹，Yikun Kang²，Zhong Dai³，Jie Ju²，Jiayu Wang²，Pin Zhang²，Fei Ma²，Binghe Xu⁴，Peng Yuan¹（Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Comprehensive Oncology, Huanxing Cancer Hospital；Department of Medical Oncology and Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College）.Combined chemo-endocrine therapy as a potential new option for HR+/HER2- advanced breast cancer：a prospective study of fulvestrant plus oral vinorelbine[J].Cancer Biology & Medicine,2023,第4期 Yuqing Wang^1,2，Ruihao Huang¹，Zheng Wang¹，Jingkang Xiong¹，Xiaoqi Wang¹，Xi Zhang^1,2（Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University；Jinfeng Laboratory）.Facing challenges with hope：universal immune cells for hematologic malignancies[J].Cancer Biology & Medicine,2023,第4期 Wenzhe Yi^1,2，Dan Yan^1,3，Dangge Wang^1,2,4，Yaping Li^1,2,5（State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences；University of Chinese Academy of Sciences；Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University；Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica；Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery）.Smart drug delivery systems to overcome drug resistance in cancer immunotherapy[J].Cancer Biology & Medicine,2023,第4期 Hengjun Zhang，Mozhi Wang，Yingying Xu（Department of Breast Surgery, The First Hospital of China Medical University）.Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment：from the perspective of inflammation[J].Cancer Biology & Medicine,2023,第4期 Qirou Wu，Xiaohong Leng，Pinglong Xu（MOE Laboratory of Biosystems Homeostasis and Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University；Institute of Intelligent Medicine, Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University (HIC-ZJU)；Cancer Center, Zhejiang University）.Erratum to Intercellular transmission of cGAS-STING signaling in cancer[J].Cancer Biology & Medicine,2023,第4期 Tiancheng Zhang¹，Youpei Lin¹，Qiang Gao^1,2,3（Department of Liver Surgery and Transplantation, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Liver Cancer Institute, Zhongshan Hospital, Fudan University；Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University；State Key Laboratory of Genetic Engineering, Fudan University）.Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy[J].Cancer Biology ＆ Medicine,2023,第3期 Yusong Wang¹，Mozhi Wang¹，Keda Yu²，Shouping Xu³，Pengfei Qiu⁴，Zhidong Lyu⁵，Mingke Cui⁶，Qiang Zhang⁶，Yingying Xu¹（Department of Breast Surgery, The First Hospital of China Medical University；Department of Breast Surgery, Fudan University Shanghai Cancer Center；Department of Breast Surgery, Harbin Medical University Cancer Hospital；Breast Cancer Center, Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Science；Breast Center, The Affiliated Hospital of Qingdao University；Department of Breast Surgery, Liaoning Cancer Hospital and Institute）.A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity[J].Cancer Biology ＆ Medicine,2023,第3期 Tianxing Zhou²，Quan Man^2,3，Xueyang Li^2,4，Yongjie Xie²，Xupeng Hou^2,4，Hailong Wang，Jingrui Yan²，Xueqing Wei，Weiwei Bai²，Ziyun Liu^2,4，Jing Liu^2,4，Jihui Hao²（Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer；Department of Hepatopancreatobiliary Surgery, Tongliao City Hospital；Department of Breast Oncoplastic Surgery；Department of Breast Oncoplastic Surgery；Department of Cancer Cell Biology；Department of Cancer Cell Biology；Department of Diagnostic and Therapeutic Ultrasonography,Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education）.Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma[J].Cancer Biology ＆ Medicine,2023,第3期 Jiali Zhang，Bin Liu，Minchao Lyu，Yourong Duan（State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine,Shanghai Jiao Tong University）.Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer[J].Cancer Biology ＆ Medicine,2023,第3期 Changhao Chen^1,2，Yuming Luo，Hanhao Zheng^1,2，Dingwen Zhang，Yao Kong，Jiabin Yang，Mingjie An^1,2，Yan Lin^1,2，Daowei Lin^2,4，Rufu Chen（Department of Urology, Sun Yat-sen Memorial Hospital, Sun Y at-sen University；Guangdong Pr ovincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China；Department of Pancreatic Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences；Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University）.Extracellular vesicle-mediated heterogeneous communication between cancer and the lymphatic system facilitates lymphatic metastasis[J].Cancer Biology ＆ Medicine,2023,第3期 FanHu＊，YinPeng＊，Xinmin Fan，Xiaojing Zhang，Zhe Jin（Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases,Department of Pathology,School of Basic Medical Sciences,Medical School, Shenzhen University）.Circular RNAs: implications of signaling pathways and bioinformatics in human cancer[J].Cancer Biology ＆ Medicine,2023,第2期 Jiaming Liu，Lu Yao，Jie Sun，Li Hu，Jiuan Chen，Juan Zhang，Ye Xu，Yuntao Xie（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Familial & Hereditary Cancer Center, Peking University Cancer Hospital & Institute）.Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer[J].Cancer Biology ＆ Medicine,2023,第2期 Zhao Bi¹，Xue'er Wang，Pengfei Qiu¹，Peng Chen¹，Yongsheng Wang¹（Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences；Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer）.Optimization of regional nodal irradiation in the era of sentinel lymph node biopsy[J].Cancer Biology ＆ Medicine,2023,第2期 Ping Li¹，Yang Liu²，Yun Liang³，Jian Bo⁴，Sujun Gao⁵，Yongxian Hu⁶，Yu Hu⁷，He Huang⁶，Xiaojun Huang，Hongmei Jing¹⁰，Xiaoyan Ke¹⁰，Jianyong Li¹¹，Yuhua Li¹²，Qifa Liu¹³，Peihua Lu¹⁴，Heng Mei⁷，Ting Niu¹⁵，Yongping Song¹⁶，Yuqin Song¹⁷，Liping Su¹⁸，Sanfang Tu¹²，Jianxiang Wang¹⁹，Depei Wu²⁰，Zhao Wang²¹，Kailin Xu²²，Zhitao Ying¹⁷，Qingming Yang²，Yajing Zhang²，Fengxia Shi²，Bin Zhang²³，Huilai Zhang，Xi Zhang²⁵，Mingfeng Zhao²⁶，Weili Zhao²⁷，Xiangyu Zhao，Liang Huang²⁸，Jun Zhu¹⁷，Wenbin Qian³，Weidong Han²，Aibin Liang¹（Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine；Department of Bio-therapeutic, Chinese PLA General Hospital；Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University；Department of Hematology,Chinese PLA General Hospital；Department of Hematology, The First Hospital of Jilin University；Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine,Zhejiang University；Institute of Hematology, Union Hospital of Tongji Medical College Huazhong University of Science and Technology；Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation；Department of Hematology, Lymphoma Research Center, Peking University Third Hospital；Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital；Department of Hematology, Zhujiang Hospital, Southern Medical University；Department of Hematology, Nanfang Hospital, Southern Medical University；Lu Daopei Institute of Hematology；Department of Hematology, West China Hospital, Sichuan University；The Affiliated Cancer Hospital of Zhengzhou University；Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute；Department of Hematology, Shanxi Cancer Hospital；State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Division of Pediatric Blood Disease Center,Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College；Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases；Department of Hematology,Beijing Friendship Hospital, Capital Medical University；Department of Hematology, The Affilia）.2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma[J].Cancer Biology ＆ Medicine,2023,第2期首页上一页 1 2 3 4 下一页尾页共有4页，转到页

期刊文章列表